Medivation Inc. buy melinda
Start price
03.03.13
/
50%
€17.65
Target price
03.09.13
€19.00
Performance (%)
19.95%
End price
03.09.13
€21.17
Summary
This prediction ended on 03.09.13 with a price of €21.17. The BUY prediction by melinda finished with a performance of 19.95%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Medivation Inc. | - | - | - | - |
| iShares Core DAX® | 0.611% | -2.723% | 14.325% | 14.359% |
| iShares Nasdaq 100 | -0.208% | 6.703% | 37.781% | 55.710% |
| iShares Nikkei 225® | 1.298% | 1.009% | 9.641% | 4.825% |
| iShares S&P 500 | 0.636% | 5.035% | 30.827% | 48.685% |
Comments by melinda for this prediction
In the thread Medivation Inc. diskutieren
schwere Krankheiten Behandlung
Medivation Inc. biopharmazeutische in Zusammenarbeit mit Pfizer über Krankheiten (alzh / Prostata) bekannt
(Laufzeit überschritten)